Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Bartoletti

Showing results (121-130 of 209) with videos related to

Pageof 21
Sort By:
Infectious Diseases and Therapy|March 3, 2025
Cefiderocol for the Treatment of Nosocomial Bloodstream Infections Caused by Stenotrophomonas maltophilia: A Case Series and Literature ReviewAntonio Vena, Laura Mezzogori, Nadia Castaldo, et al.
Hematological Oncology|July 15, 2023
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infectionZeno Pasquini, Alice Toschi, Beatrice Casadei, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 9, 2023
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposureRossana Roncato, Elena Peruzzi, Lorenzo Gerratana, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 25, 2021
ESCMID COVID-19 living guidelines: drug treatment and clinical managementMichele Bartoletti, Ozlem Azap, Aleksandra Barac, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 23, 2022
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groupsClorinda Schettino, Lucia Musacchio, Michele Bartoletti, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|March 28, 2012
Toscana virus infections in northern Italy: laboratory and clinical evaluationCaterina Vocale, Michele Bartoletti, Giada Rossini, et al.
Frontiers in Microbiology|January 2, 2025
Distinct chromosomal mutation associated with cefiderocol resistance in <i>Acinetobacter baumannii</i>: a combined bioinformatics and mass spectrometry approach to unveil and validate the <i>in vivo</i>-acquired chemoresistanceLavinia Morosi, Davide Golzato, Linda Bussini, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 2022
Treatment duration for central line-associated infection caused by Enterococcus spp.: a retrospective evaluation of a multicenter cohortElena Rosselli Del Turco, Zeno Pasquini, Kristian Scolz, et al.
JPRAS Open|July 1, 2026
Reducing the burden of breast implant infections through a structured multidisciplinary pathwayRoberta Comunian, Stefano Vaccari, Edoardo Caimi, et al.
Journal of Global Antimicrobial Resistance|May 15, 2022
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective studyLinda Bussini, Elena Rosselli Del Turco, Zeno Pasquini, et al.
Pageof 21

Showing results (121-130 of 209) with videos related to

Sort By:
Pageof 21
Infectious Diseases and Therapy|March 3, 2025
Cefiderocol for the Treatment of Nosocomial Bloodstream Infections Caused by Stenotrophomonas maltophilia: A Case Series and Literature ReviewAntonio Vena, Laura Mezzogori, Nadia Castaldo, et al.
Hematological Oncology|July 15, 2023
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infectionZeno Pasquini, Alice Toschi, Beatrice Casadei, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 9, 2023
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposureRossana Roncato, Elena Peruzzi, Lorenzo Gerratana, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 25, 2021
ESCMID COVID-19 living guidelines: drug treatment and clinical managementMichele Bartoletti, Ozlem Azap, Aleksandra Barac, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 23, 2022
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groupsClorinda Schettino, Lucia Musacchio, Michele Bartoletti, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|March 28, 2012
Toscana virus infections in northern Italy: laboratory and clinical evaluationCaterina Vocale, Michele Bartoletti, Giada Rossini, et al.
Frontiers in Microbiology|January 2, 2025
Distinct chromosomal mutation associated with cefiderocol resistance in <i>Acinetobacter baumannii</i>: a combined bioinformatics and mass spectrometry approach to unveil and validate the <i>in vivo</i>-acquired chemoresistanceLavinia Morosi, Davide Golzato, Linda Bussini, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 2022
Treatment duration for central line-associated infection caused by Enterococcus spp.: a retrospective evaluation of a multicenter cohortElena Rosselli Del Turco, Zeno Pasquini, Kristian Scolz, et al.
JPRAS Open|July 1, 2026
Reducing the burden of breast implant infections through a structured multidisciplinary pathwayRoberta Comunian, Stefano Vaccari, Edoardo Caimi, et al.
Journal of Global Antimicrobial Resistance|May 15, 2022
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective studyLinda Bussini, Elena Rosselli Del Turco, Zeno Pasquini, et al.
Pageof 21